UK OEM Patient Monitoring and Vital Sign OEM Module Market

ID: MRFR/MED/51638-HCR
200 Pages
Satyendra Maurya
Last Updated: March 28, 2026
UK OEM Patient Monitoring Vital Sign OEM Module Market Research Report By Product Type (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Fetal & Neonatal Monitoring Devices, Respiratory Monitoring Devices, Remote Patient Monitoring Devices, Temperature Monitoring Devices, Others) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK OEM Patient Monitoring and Vital Sign OEM Module Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.77%
2024 Market Size$ 0.47 Billion
2025 Market Size$ 0.5 Billion
2035 Market Size$ 0.88 Billion

Key Players

Philips
GE Healthcare
Siemens Healthineers
Medtronic
Nihon Kohden
Schiller AG
Trends
  • Technological Advancements in Monitoring Devices
  • Focus on Patient-Centric Solutions
  • Regulatory Compliance and Safety Standards
Opportunities
  • Government Initiatives and Funding
  • Rising Prevalence of Chronic Diseases
  • Focus on Integrated Healthcare Solutions
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Cardiac Monitoring
      2. 4.1.2 Respiratory Monitoring
      3. 4.1.3 Neurological Monitoring
      4. 4.1.4 Multi-parameter Monitoring
    2. 4.2 Healthcare, BY End Use (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Home Care Settings
      3. 4.2.3 Ambulatory Surgical Centers
      4. 4.2.4 Long-term Care Facilities
    3. 4.3 Healthcare, BY Technology (USD Billion)
      1. 4.3.1 Wireless Technology
      2. 4.3.2 Wired Technology
      3. 4.3.3 Cloud-based Technology
      4. 4.3.4 Portable Technology
    4. 4.4 Healthcare, BY Product Type (USD Billion)
      1. 4.4.1 Wearable Monitors
      2. 4.4.2 Non-wearable Monitors
      3. 4.4.3 Handheld Monitors
      4. 4.4.4 Stationary Monitors
    5. 4.5 Healthcare, BY Patient Type (USD Billion)
      1. 4.5.1 Adult Patients
      2. 4.5.2 Pediatric Patients
      3. 4.5.3 Geriatric Patients
      4. 4.5.4 Critical Care Patients
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Philips (GB)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GE Healthcare (GB)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (GB)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Medtronic (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Nihon Kohden (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Schiller AG (GB)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Mindray (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Welch Allyn (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Drager (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 UK MARKET ANALYSIS BY APPLICATION
    3. 6.3 UK MARKET ANALYSIS BY END USE
    4. 6.4 UK MARKET ANALYSIS BY TECHNOLOGY
    5. 6.5 UK MARKET ANALYSIS BY PRODUCT TYPE
    6. 6.6 UK MARKET ANALYSIS BY PATIENT TYPE
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    17. 6.17 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    19. 6.19 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    21. 6.21 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
      3. 7.2.3 BY TECHNOLOGY, 2026-2035 (USD Billion)
      4. 7.2.4 BY PRODUCT TYPE, 2026-2035 (USD Billion)
      5. 7.2.5 BY PATIENT TYPE, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

UK OEM Patient Monitoring and Vital Sign OEM Module Market Segmentation

UK OEM Patient Monitoring and Vital Sign OEM Module Market By Application (USD Billion, 2026-2035)

  • Cardiac Monitoring
  • Respiratory Monitoring
  • Neurological Monitoring
  • Multi-parameter Monitoring

UK OEM Patient Monitoring and Vital Sign OEM Module Market By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Long-term Care Facilities

UK OEM Patient Monitoring and Vital Sign OEM Module Market By Technology (USD Billion, 2026-2035)

  • Wireless Technology
  • Wired Technology
  • Cloud-based Technology
  • Portable Technology

UK OEM Patient Monitoring and Vital Sign OEM Module Market By Product Type (USD Billion, 2026-2035)

  • Wearable Monitors
  • Non-wearable Monitors
  • Handheld Monitors
  • Stationary Monitors

UK OEM Patient Monitoring and Vital Sign OEM Module Market By Patient Type (USD Billion, 2026-2035)

  • Adult Patients
  • Pediatric Patients
  • Geriatric Patients
  • Critical Care Patients

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035